Physician profile
Ellen D Pan
NPI 1003813247
$1,918.98
in general payments reported to CMS, 2019-2025
18 companies · $452 in 2025
The $452 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $350 · 2020: $119 · 2021: $136 · 2022: $241 · 2023: $419 · 2024: $203 · 2025: $452.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,073.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,073.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $317.21 | 2022-2025 | Xiidra, Miebo, Vyzulta |
| Abbvie INC. | $241.32 | 2023-2025 | |
| Sun Pharmaceutical Industries INC. | $229.76 | 2019-2023 | Cequa |
| Alcon Vision LLC | $216.42 | 2022-2025 | Hydrus Microstent, Rocklatan |
| Novartis Pharmaceuticals Corporation | $194.98 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $163.60 | 2019-2021 | |
| Oyster Point Pharma, INC. | $132.56 | 2022-2025 | Tyrvaya, Ryzumvi |
| Shire North American Group INC | $95.22 | 2019 | |
| Allergan, INC. | $92.11 | 2019-2021 | |
| Amgen INC. | $58.75 | 2024 | Tepezza |
| Mallinckrodt Hospital Products INC. | $29.99 | 2025 | Acthar |
| Dompe US, INC. | $25.91 | 2025 | Oxervate |
| Biotissue Holdings INC. | $25.67 | 2023 | |
| Harrow Eye, LLC | $21.25 | 2024 | Vevye |
| Eyevance Pharmaceuticals LLC | $20.02 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $19.09 | 2019 | |
| Kala Pharmaceuticals, INC. | $17.88 | 2019 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Pan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.